current user: public

If you have questions about the server, please let us know.

Query: 6b5v_A mol:protein length:730 Transient receptor potential cation channel subfamily V member 5, from PDB1018

Results of FFAS03 search in PDB1018
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .  630    .  640    .  650    .  660    .  670    .  680    .  690    .  700    .  710    .  720    .  730
# Score Template Links and tools%idFirst MGACPPKAKGPWAQLQKLLISWPVGEQDWEQYRDRVNMLQQERIRDSPLLQAAKENDLRLLKILLLNQSCDFQQRGAVGETALHVAALYDNLEAATLLMEAAPELAKEPALCEPFVGQTALHIAVMNQNLNLVRALLARGASVSARATGAAFRRSPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDEHSDHLQSLELVPNHQGLTPFKLAGVEGNTVMFQHLMQKRKHVQWTCGPLTSTLYDLTEIDSWGEELSFLELVVSSKKREARQILEQTPVKELVSFKWKKYGRPYFCVLASLYILYMICFTTCCIYRPLKLRDDNRTDPRDITILQQKLLQEAYVTHQDNIRLVGELVTVTGAVIILLLEIPDIFRVGASRYFGQTILGGPFHVIIITYASLVLLTMVMRLTNMNGEVVPLSFALVLGWCSVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFHITFQTEDPNNLGEFSDYPTALFSTFELFLTIIDGPANYSVDLPFMYCITYAAFAIIATLLMLNLFIAMMGDTHWRVAQERDELWRAQVVATTVMLERKMPRFLWPRSGICGYEYGLGDRWFLRVENHHDQNPLRVLRYVEAFKCSDKEDGQEQLSEKRPSTVESGMLSRASVAFQTPSLSRTTSQSSNSHRGWEILRRNTLGHLNLGLDLGEGDGEEVYHFLast
1 -226.0006b5v_A mol:protein length:730 Transient receptor potential cation channel subfamily V member 5  ali model  100  1MGACPPKAKGPWAQLQKLLISWPVGEQDWEQYRDRVNMLQQERIRDSPLLQAAKENDLRLLKILLLNQSCDFQQRGAVGETALHVAALYDNLEAATLLMEAAPELAKEPALCEPFVGQTALHIAVMNQNLNLVRALLARGASVSARATGAAFRRSPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDEHSDHLQSLELVPNHQGLTPFKLAGVEGNTVMFQHLMQKRKHVQWTCGPLTSTLYDLTEIDSWGEELSFLELVVSSKKREARQILEQTPVKELVSFKWKKYGRPYFCVLASLYILYMICFTTCCIYRPLKLRDDNRTDPRDITILQQKLLQEAYVTHQDNIRLVGELVTVTGAVIILLLEIPDIFRVGASRYFGQTILGGPFHVIIITYASLVLLTMVMRLTNMNGEVVPLSFALVLGWCSVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFHITFQTEDPNNLGEFSDYPTALFSTFELFLTIIDGPANYSVDLPFMYCITYAAFAIIATLLMLNLFIAMMGDTHWRVAQERDELWRAQVVATTVMLERKMPRFLWPRSGICGYEYGLGDRWFLRVENHHDQNPLRVLRYVEAFKCSDKEDGQEQLSEKRPSTVESGMLSRASVAFQTPSLSRTTSQSSNSHRGWEILRRNTLGHLNLGLDLGEGDGEEVYHF 730
2 -193.0006bo8_A mol:protein length:742 Transient receptor potential cation channel subfamily V member 6  ali model follow..  71  2..GLSLPKEKGLIKFCRWFQRRESWAQS----RDEQNLLQQKRIWESPLLLAAKDNDVQALNKLLKYEDCKVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVVNQNMNLVRALLARRASVSARATGTAFRRSPCNLIYFGEHPLSFAACVNSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDRHGDHLQPLDLVPNHQGLTPFKLAGVEGNTVMFQHLMQKRKHTQWTYGPLTSTLYDLTEIDSSGDEQSLLELIITTKKREARQILDQTPVKELVSLKWKRYGRPYFCMLGAIYLLYIICFTMCCIYRPLKPRTNNRTSPRDNTLLQQKLLQEAYMTPKDDIRLVGELVTVIGAIIILLVEVPDIFRMGVTRFFGQTILGGPFHVLIITYAFMVLVTMVMRLISASGEVVPMSFALVLGWCNVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFYIIFQTEDPEELGHFYDYPMALFSTFELFLTIIDGPANYNVDLPFMYSITYAAFAIIATLLMLNLLIAMMGDTHWRVAHERDELWRAQIVATTVMLERKLPRCLWPRSGICGREYGLGDRWFLRVEDRQDLNRQRIQRYAQAFHTRGSEDLDKDSVEKLELGCPFS-------PHLSLPMPSVSRSTSRSSANWERLRQGTLRRDLRGII--EDGESWEYQI 725
3 -188.0006e2g_A mol:protein length:727 Transient receptor potential cation channel subfamily V member 6  ali model follow..  73  14.CLWNKFCRWFHRRESWAQSR------------DEQNLLQQKRIWESPLLLAAKENNVQALIKLLKFEGCEVHQKGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDH-LKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRKHIQWTYGPLTSTLYDLTEIDSSGDDQSLLELIVTTKKREARQILDQTPVKELVSLKWKRYGRPYFCVLGAIYVLYIICFTMCCVYRPLKPRITNRTNPRDNTLLQQKLLQEAYVTPKDDLRLVGELVSIVGAVIILLVEIPDIFRLGVTRFFGQTILGGPFHVIIVTYAFMVLVTMVMRLTNSDGEVVPMSFALVLGWCNVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFYIIFQTEDPDELGHFYDYPMALFSTFELFLTIIDGPANYDVDLPFMYSITYAAFAIIATLLMLNLLIAMMGDTHWRVAHERDELWRAQVVATTVMLERKLPRCLWPRSGICGREYGLGDRWFLRVEDRQDLNRQRIRRYAQAFQQQDDLY-SEDLEKDSGEKLEMARPFGAYLSFPTPSVSRSTSR---SSTNWDRLRQGALGIINRGLEDGEGWEYQI... 727
4 -174.0005wo7_A mol:protein length:676 Transient receptor potential cation channel subfamily V member 6  ali model follow..  76  1..............MGWSLPKEKGLILCWAQSRDEQNLLQQKRIWESPLLLAAKENNVQALYKLLKFEGCEVHQKGAMGETALHIAALYDNNEAAQVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDH-LKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRKHIQWTYGPLTSTLYDLTEIDSSGDDQSLLELIVTTKKREARQILDQTPVKELVSLKWKRYGRPYFCVLGAIYVLYIICFTMCCVYRPLKPRITNRTNPRDNTLLQQKLLQEAYVTPKDDLRLVGELVSIVGAVIILLVEIPDIFRLGVTRFFGQTILGGPFHVIIVTYAFMVLVTMVMRLTNSDGEVVPMSFALVLGWCNVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFYIIFQTEDPDELGHFYDYPMALFSTFELFLTIIDGPANYDVDLPFMYSITYAAFAIIATLLMLNLLIAMMGDTHWRVAHERDELWRAQVVATTVMLERKLPRCLWPRSGICGREYGLGDRWFLRVEDRQDLNRQRIRRYAQAFQQQDDLYSEDLEKDSGEKLVPR......................................................... 672
5 -147.0006dvw_A mol:protein length:791 Transient receptor potential cation channel subfamily V member 3  ali model follow..  24  61.PPIFSKPMDSNIRQCLSGNCDDMDSPQSPQNLAKEEQRQKKKRLKKRIFAAVSEGCVEELRELL-QDLQDLCRRSDTGKTCLMKALLNNTKEIVRILLAFAEEFINAEYTEEAYEGQTALNIAIERRQGDITAVLIAAGADVNAHAKGVFFNKYQHEGFYFGETPLALAACTNQPEIVQLLMENQTDITSQDSRGNNILHALVTVAEDKTQNDFVKRMYDMILLRSGNWELETMRNNDGLTPLQLAAKMGKAEILKYILSREIKTDWAYGPVSSSLYDLTNVDTTTDNSVLEIIVYNTNIDNRHEMLTLEPLHTLLHTKWKKFAKYMFFLSFCFYFFYNITLTLVSYYRPRE--------------DEDLPHPLALTHKMSWLQLLGRMFVLIWATCISVKEGIAIFLLRPSD-LQSILSDAWFHFVFFVQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYILFLLGFGVALASLIEKKDKKDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSTYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRFRMGELCKDEDFRLCLRINEVKWTEWKTHVSFLNEDPGPIRRTADLNKIQDSSRSNSKTTLYAFDELDEFPETS......................................... 790
6 -145.0006bwj_A mol:protein length:776 Transient receptor potential cation channel subfamily V member 2  ali model follow..  23  7.PAFRLETSDGGQDGAEVDKAQLIKVNLNYRKGAGASQPDLNRFDRDRLFNVVARGNPEDLAGLLKYLTDSEYTEGSTGKTCLMKAVLNGVNACIQPLLEIDRDLVNAQCTDEYYRGHSALHIAIEKRSLQCVKLLVENGANVHAKACGHFFQKNQDTCFYFGELPLSLAACTKQWDVVNYLLENPASLQAQDSLGNTVLHALVMIADDSLVVRMYDGLLQAGARLCPNVQLEGIPNLEGLTPLKLAAKEGKIEIFKHILQREFSAPWCYGPVRVSLYDLASVDSWEENSVLEIIAFHSRSPHRHRMVVLEPLNKLLQAKWDRLIP-RFCFNFLCYLVYMLIFTAVAYHQP---------------ALEKQGFPPLKATAGNSMLLLGHILILLGGVYLLLGQLWYFWRRRLFIWI--SFMDSYSEILFLLQALLTVLSQVLCFLAIEWYLPLLVSSLVMGWTNLLYYTRGFQHTGIYSVMIEKVILRDLLRFLLVYLVFLFGFAVALVSLSREAQNSRTPPYRSILDASLELFKFTIGMGELAFQEQLRFRGVVLLLLLAYVLLTYVLLLNMLIALMSETVNSVATDSWSIWKLQKAISVLEMENGYWWCRRKKQRAGVMDGSPDERWCFRVGEMN---WATWEQTLPRTLCEEPSGAAAPGVMKNPTPASQRGEDSASEEDHLPLQLLQSRDYKDDDD.............................. 768
7 -139.0005irx_A mol:protein length:636 Transient receptor potential cation channel subfamily V member 1  ali model follow..  26  2......................................MGSRLYDRRSIFDAVAQSNCQELESLLKRLTDSEFKDPETGKTCLLKAMLNGQNDTIALLLDVARKTDNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSADISARDSVGNTVLHALVEVADNTVDNSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKN----------------TVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPS--LKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIED------GKYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLDGKDDYRWCFRVDE------VNWTTWNTNVGIINEDPG....................................................................... 636
8 -138.0006c8f_A mol:protein length:675 Transient receptor potential cation channel, subfamily V, member 4  ali model follow..  28  1..............................MAPSPDPPPVIKMFNRHMLFDIVSRGSTAELEGFLKRLTDEEFREASTGKTCLTKALMNGKNDTIPMLIDIAEKTGNSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFPKDEGGYFYFGELPLSLAACTNQPDIVHYLTENAADIRRQDSRGNTVLHALVAIADNTFVTKVYDLLVIKCVKLYPDSSLEAIFNNDSMSPLMMAAKLGKIGIFQHIIRLEIKRDWAYGPVYSSLYDLSMLDTCGEEVSVLELVYNSKVENRHEMLAVEPINELLRDKWQKFGAVSFYISVVSYLIAMIIFTLIAYYRPMDGTPPYP-----------------YRTTMDYMRLAGEIVTLLTGVVFFITNIKDLFMKK-CPGVNSLFIDGSFQLLYFIYSVLVIITAVLYLVGIESYLAVMVFALVLGWMNALYFTRGLKLTGTYSIMLQKILFKDLFRFLLVYLLFMIGYASALVSLLNPCTSQECRDSSTFSKFLLDLFKLTIGMGDLEMINSAKYPAVFIILLVTYIILTFVLLLNMLIALMGETVGQVSKESKQIWKLQWATTILDIERSFPVCMRKAFRSGEMDGTPDRRWCFRVDEVNWSHWNQNLGIINEDPGRSNS......................................................................... 669
9 -138.0005an8_A mol:protein length:613 TRPV2  ali model follow..  26  2...............................................RLFNVVARGNPEDLAGLL-EYLRRTSKEGSTGKTCLMKAVLNGVNACIQPLLEIDRDLVNAQCTDEYYRGHSALHIAIEKRSLQCVKLLVENGANVHAKACGHFFQKNQDTCFYFGELPLSLAACTKQWDVVNYLLENAASLQAQDSLGNTVLHALVMIADNSLVVRMYDGLLQAGARLCPNVQLEGIPNLEGLTPLKLAAKEGKIEIFKHILQREFSAPWCYGPVRVSLYDLASVDSWEENSVLEIIAFHSRSPHRHRMVVLEPLNKLLQAKWDRLIP-RFCFNFLCYLVYMLIFTAVAYHQP---------------ALEKQGFPPLKATAGNSMLLLGHILILLGGVYLLLGQLWYFWRRRLFIWI--SFMDSYFEILFLLQALLTVLSQVLCFLAIEWYLPLLVSSLVLGWLNLLYYTRGFQHTGIYSVMIQKVILRDLLRFLLVYLVFLFGFAVALVSLSREAQEDEAPPYRSILDASLELFKFTIGMGELAFQEQLRFRGVVLLLLLAYVLLTYVLLLNMLIALMSETVNSVATDSWSIWKLQKAISVLEMENGYWWCRRKKQRAGVMLTSPDERWCFRVGE............................................................................................... 612
10 -136.0006bbj_A mol:protein length:868 Transient receptor potential cation channel, subfamily V, member 4  ali model follow..  26  67.IRFQGPFRKGISNPMDLLESTIYESSAPKK-PSPDPPPVIKMFNRHMLFDIVSRGSTAELEGFLKRLTDEEFREASTGKTCLTKALMNGKNDTIPMLIDIAEKFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQKDEGGYFYFGELPLSLAACTNQPDIVHYLTENAADIRRQDSRGNTVLHALVAIADNTRENKVYDLLVIKCVKLYPDSSLEAIFNNDSMSPLMMAAKLGKIGIFQHIIRLEIKRDWAYGPVYSSLYDLSMLDTCGEESVLEILVYNSKVENRHEMLAVEPINELLRDKWQKFGAVSFYISVVSYLIAMIIFTLIAYYRPMDGTPPY-----------------PYRTTMDYMRLAGEIVTLLTGVVFFITNIKDLFMKK-CPGVNSLFIDGSFQLLYFIYSVLVIITAVLYLVGIESYLAVMVFALVLGWMNALYFTRGLKLTGTYSIMLQKILFKDLFRFLLVYLLFMIGYASALVSLLNPCTSQECRDSSTFSKFLLDLFKLTIGMGDLEMINSAKYPAVFIILLVTYIILTFVLLLNMLIALMGETVGQVSKESKQIWKLQWATTILDIERSFPVCMRKAFRSGEMDGTPDRRWCFRVDEVNWSHWNQNLGIINEDPGRNDGYQYYGFSQTVPRVVELNKAPQHSDDVVVPLGNIPQVQTYSQRQENAQNWKKDETHI................. 868
11 -134.0006mho_B mol:protein length:826 Transient receptor potential cation channel subfamily V member 3  ali model follow..  23  29.EKRPAEITPTKKSAHFFLEIEGFEPNPTVAKTAKEEQRRKKRRLKKRIFAAVSEGCVEELVELLVELQELCRTASDTGKTCLMKALLNNTKEIVRILLAFAEEFINAEYTEEAYEGQTALNIAIERRQGDIAALLIAAGADVNAHAKGAFFNKYQHEGFYFGETPLALAACTNQPEIVQLLMEHQTDITSRDSRGNNILHALVTVAEDDFVKRMYDMILLRSGNW----ELETTRNNDGLTPLQLAAKMGKAEILKYILSREIKTDWAYGPVSSSLYDLTNVDTTTDNSVLEITVYNTNIDNRHEMLTLEPLHTLLHMKWKKFAKHMFFLSFCFYFFYNITLTLVSYYRPREEEAIPHPLA--------------LTHKMGWLQLLGRMFVLIWAMCISVKEGIAIFLLRPSD-LQSILSDAWFHFVFFIQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYIVFLLGFGVALASLIEKCPKDDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSKYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRMGELCKVAEDDFRLCLRINEVKWTEWKTHVSFLN--------EDPGPVRRTDFNKIQDSSRNNSKTTLNAFEEVEEFPETSVVDAGLEVLFQGPAAAVDYKDDDDKA........ 816
12 -132.0003j5p_B mol:protein length:598 Transient receptor potential cation channel subfamily V member 1  ali model follow..  27  2...........................................YDRRSIFDAVAQSNCQELESLLKKRLTDSEKDPETGKTCLLKAMLNGQNDTIALLLDVARKTDNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSADISARDSVGNTVLHALVEVADNTVDNSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKN----------------TVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPS--LKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIED------GKYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAXXXXXXXXXXXX....................................................................................................... 598
13 -130.0005hi9_A mol:protein length:770 Transient Receptor Potential Cation Channel Subfamily V Member 2  ali model follow..  23  33.PPMESPFQREDRNSSPQIKVNLNFIKRPPKNTSAPSQQEPDRFDRDRLFSVVSRGVPEELTGLLKYLTDSAYTEGSTGKTCLMKAVLNGVNACIMPLLQIDKDLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPASLEATDSLGNTVLHALVMIADNSLVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSTEWCYGPVRVSLYDLSSVDSWEKNSVLEIIAFHCKSPNRHRMVVLEPLNKLLQEKWDRLVSRFFF-NFACYLVYMFIFTVVAYHQP---------------SLDQPAIPSSKATFGESMLLLGHILILLGGIYLLLGQLWYFWRRRLFIWI--SFMDSYFEILFLLQALLTVLSQVLRFMETEWYLPLLVLSLVLGWLNLLYYTRGFQHTGIYSVMIQKVILRDLLRFLLVYLVFLFGFAVALVSLSREARSEEPAPYRSILDASLELFKFTIGMGELAFQEQLRFRGVVLLLLLAYVLLTYVLLLNMLIALMSETVNHVADNSWSIWKLQKAISVLEMENGYWWCRRKKHREGRLDGTPDERWCFRVEEVNWAAWEKTLPTLSEDPSGPGITGNKKNPTSKPGKNSASEEDHLPLQVLQSPTETSQVAPA.................................. 770
14 -75.2005vkq_A mol:protein length:1732 No mechanoreceptor potential C isoform L  ali model follow..  14  931.TPLHVAAYYGQADTVRELLTSVPATKSETPTGQSLFGDLGTESGMTPLHLAAFSGNENVVRLLLNSAGVQVDAATENGYNPLHLACFGGHMSVVGLLLSRSAELLQS----QDRNGRTGLHIAAMHGHIQMVEILLGQGAEINATDRN-------------GWTPLHCAAKAGHLEVVKLLCEAGASPKSETNYGCAAIWFAASEGHNEVLRYLMNKEHDTYGLMEDLVSPAPVDTAAKLSNIYIVLSTKEKERAKDLVAAGKQCEAMATELLALA-KILQATDKRNVEFLDVLIENEQKEVIAQRYLQELWHGSLTWASWKILLLLVAFIVCPPVWIGFTFPMGHKFNKIKFMSYLTSHIYLMIHLSIVGITPIYPVLRLSVPYWYEVGLLIWLSGLLLFELTNPSDKSGLGSIKVLVLLLGMAGVGVHVSAFLFVSKEYWPTLVYCRNQCFALAFLLACVQILDFLSFHHLFGPWAIIIGDLL-KDLARFLAVLAIFVFGFSMHIVALNQSFANFSPEDLRSFENSFELLFFAVFGQTTTEQTQVDKIKYLFKIVFGIYMLVSVVVLIQLLIAMMSDTYQRIQAQSDIEWKFGLSKLIRNMHRT---------TTAPSPLNLVTTWFMWIVEKVKARMKKKKRPSLVQMMGIRQASPRTKAGAKWLSKIKKDSVALSQVHLSPLGSQASFSQANQNRDWEAIAKKYRALVGDEEGGSLKDSDA.... 1701
15 -72.2005z96_A mol:protein length:755 Short transient receptor potential channel 4  ali model follow..  13  1MAQFYYKRNVNAPYRDRIPLRI-------------VRAESELSPSEKAYLNAVEKGDYASVKKSLEEAEININCIDPLGRTALLIAIENENLELIELLLSFNVYVG------------DALLHAIRKEVVGAVELLLNHKKPSGEKQVPPILLDKQFSEFTPDITPIILAAHTNNYEIIKLLVQKGVSVPRPHEVRCNCVECVSSSDVDSLRHSRSRLNIYKALASPSLIAL------SSEDPFLTAFQLSWE--LQELSKVENEFKSEYEELSRAKDLLDQTRSSRELEIILNYRDDNSLIEEQSGNDLARLKLAIKYRQKEFVAIKFICHTASYLTFLFLLLLASQHI-----------------------DRSDLNRQGPPPTIVEWMILPWVLGFIWGEIKQMWDGGLQDYIHDW-----WNLMDFVMNSLYLATISLKIVAFVKYEALFAIANIFSSLRLISLFTANSHLGPLQISLGRML-LDILKFLFIYCLVLLAFANGLNQLYFYYEETKNNAFSTLFETLQSLFWSIFGLINLYVTNVKAQEFVGATMFGTYNVISLVVLLNMLIAMMNNSYQLIADHADIEWKFARTKLWMSYFEELPT--------------------FNVIPSPKSLWYLVKWIWTHLCKKKMRRKPESFGTIGRRAADNLRRHHQYQEVMRNLVKRYVAAMIREAKTEEGLTEENVKELKQDISSFRFEVLGL... 753
16 -71.9003j9p_D mol:protein length:1528 Maltose-binding periplasmic protein, Transient receptor potential cation channel subfamily A member 1 chimera  ali model follow..  14  642.TPLHLAVQNGDLEMIKMCLDNGAQIDPVEKGRCTAIVNTTDGCHETMLHRASLFDHHELADYLI-SVGADINKIDSEGRSPLILATASASWNIVNLLLSKGAQVDIKDNMDEDNDGCTPLHYACRQGGPGSVNNLLGFNVSIHSKSKDKKSPRLLNEGDLHGMTPLHLAAKNGHDKVVQLLLKKGA-LFLSDHNGWTALHHASMGGYTQTMKVILD----------TNLKCTDRLDEDGNTALHFAAREGHAKAVALLLSHNADIV-LNKQQASFLHLALHIEYNFKYLQCPLEFTKKTPTQDVIYEPLTALNAMVQNNRIELLNHPVCKEYLLMKWLAYGFRAHMGLIPMTILVVNIKPGMAFNSTGIINETSDHSEILDTLIKTCMILVFLSSIFGYCKEAGQIFQQKRNYF---MDISNVLEWIIYTTGIIFVLPLFVEIPAHLQWQC--AIAVYFYWMNFLLYLQRFENCGIFIVMLEV-ILKTLLRSTVVFIFLLLAFGLSFYILLNLQDP-----FSSPLLSIIQTFSMMLGDINYRESFELAHPVLSFAQLVSFTIFVPIVLMNLLIGLAVGDIADVQKHASLKRIAMQVELHTSLEKKLPLWFLRKVDQKSTIVYPNKPRSGNADKSLEMEILKQKYRLKDLTFLLEKQHELIKLIIQKMEIISETEDDDSHCSFQDRFKKEQMEQRNSR--WNTVLRAV..................... 1511
17 -71.2006d7l_A mol:protein length:853 Short transient receptor potential channel 3  ali model follow..  11  13.RRMTVMREKGRRQAVRGPAF------------MFNDRGTSLTAEEERFLDAAEYGNIPVVRKMLEEKTLNVNCVDYMGQNALQLAVGNEHLEVTELLLKKENLARIG----------DALLLAISKGYVRIVEAILNHPGFAASKRLTLYAYDEDGTRFSPDITPIILAAHCQKYEVVHMLLMKGARIERPHDYFCKCGDCMEKQRHDSFSHSRSRI-----------NAYKGLASPAYLSLSSEDPVLTALELSNELAKLANIEKEFKNDYRKLSMQCKDLDLCRDSEEVEAILNGDLESAHRHKASLSRVKLAIKYEVKKFVAMKFVAHAASFIIFLGLLVFNASDR--------FEGITTLPNITVTDYPKQIFRVKTTQFTWTEMLIMVWVLGMMWSECKELWLEGPREYILQ------WNVLDFGMLSIFIAAFTARFLAF--SEGLYAIAVVLSFSRIAYILPANESFGPLQISLGRTV-KDIFKFMVLFIMVFFAFMIGMFILYSYYLGAKVNAFTTVEESFKTLFWSIFGLSEVTSVVHKFIENIGYVLYGIYNVTMVVVLLNMLIAMINSSYQEIEDDSDVEWKFARSKLWLSYGKTLPPIMRIVNFPKCRRRRLQKDIEMGMGNSKSRLNLFTQSNSRVFESHSFNSILNQPTRYQQIMKRLIKRYVLKAQVDKENDEVNEGELKEIKQDISSLRYELLEDKSQATEELAILIHKL... 841
18 -69.4005yx9_A mol:protein length:931 Short transient receptor potential channel 6  ali model follow..  11  30.DYLLMDSELGEDGCPQAPLPCYGYYPCFRGSDNRSDRSTSLSIEEERFLDAAEYGNIPVVRKMLEEHSLNVNCVDYMGQNALQLAVANEHLEITELLLKKENLSRVG----------DALLLAISKGYVRIVEAILSHPAFAEGKRLATSPSDEDGTRFSHDVTPIILAAHCQEYEIVHTLLRKGARIERPHDYFCKCNDCNQKQKHDSFSHSRSRI-----------NAYKGLASPAYLSLSSEDPVMTALELSNELAVLANKNDYKKLSMQCKDFVVGLLDLCRNTEEVEAILNGDVETLQSGD-NLSRLKLAIKYEVKKFVAMKFVAHAASFTIFLGLLVMNAADRFEGTKLLPNETSTDNAKQLFR--------MKTSCFSWMEMLIISWVIGMIWAECKEIWTQGPKEYLFEL-----WNMLDFGMLAIFAASFIARFMAF--SEGLYAIAVVLSFSRIAYILPANESFGPLQISLGRTV-KDIFKFMVIFIMVFVAFMIGMFNLYSYYIGAKQNEFTTVEESFKTLFWAIFGLSEVKSVVHKFIENIGYVLYGVYNVTMVIVLLNMLIAMINSSFQEIEDDADVEWKFARAKLWFSYGRTLPV-LVPSPKSLFYLLLKLKKWISELFQGHKKGFQEDAEMNKINEEKKLGILGSHEDLSKLSLDKKQVGHNKQPSIRSSEDFHLNSFNNPPRQYQKIMKKRYVLQAQIDKESDEVNEGELKEI 887
19 -68.9002rfa_A mol:protein length:232 Transient receptor potential cation channel subfamily V member 6  ali model follow..  80  2...........................................IWESPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDH-LKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRKHIAAA............................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 226
20 -65.9004dx1_A mol:protein length:259 Transient receptor potential cation channel subfamily V member 4  ali model follow..  32  2...........................................FNRPILFDIVSRGSTADLDGLLKRLTDEEFREPSTGKTCLPKALLNGRNDTIPVLLDIAERTGNSPFRDIYYRGQTALHIAIERRCKHYVELLVAQGADVHAQARGRFFQKDEGGYFYFGELPLSLAACTNQPHIVNYLTEKKADMRRQDSRGNTVLHALVAIADNTRENKMYDLLLLKCARLFPDSNLEAVLNNDGLSPLMMAAKTGKIGIFQHIIRREVTDEAA............................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 252
21 -65.6006cv9_A mol:protein length:842 Short transient receptor potential channel 6  ali model follow..  12  1....................................AMGSMLSIEEERFLDAAEYGNIPVVRKMLEEHSLNVNCVDYMGQNALQLAVANEHLEITELLLKKENLSRVG----------DALLLAISKGYVRIVEAILNHPAFAEGKRLATSPSDEDGTRFSHDVTPIILAAHCQEYEIVHTLLRKGARIERPHDYFCKCTECSQKQKHDSFSHSRSRI-----------NAYKGLASPAYLSLSSEDPVMTALELSNELAVLANIEKEFKNDYRKLSMQCKDLDLCRNTEEVEAILNGDAETRDFGRPNLSRLKLAIKYEVKKFVAMKFVAHAASFTIFLGLLVMNAADRFEGTKLLPNETSTDNARQLFR--------MKTSCFSWMEMLIISWVIGMIWAECKEIWTQGPKEYLFEL-----WNMLDFGMLAIFAASFIARFMAF--SEGLYAIAVVLSFSRIAYILPANESFGPLQISLGRTV-KDIFKFMVIFIMVFVAFMIGMFNLYSYYIGAKQNEFTTVEESFKTLFWAIFGLSEVKSVVHKFIENIGYVLYGVYNVTMVIVLLNMLIAMINSSFQEIEDDADVEWKFARAKLWFSYGRTLPV-LVPSPKSLLYLLLKFKKWMCELIQGQKQGFQEDAEMNKRNEEKKFGISGSHEDLSKFSLDKNQLAHNKQSSTRSSEDYHLNSFSNPPRQYQKIMKKRYVLQAQIDKESDEVNEGELKEI 798
22 -65.2002nyj_A mol:protein length:273 Transient receptor potential cation channel subfamily V member 1  ali model follow..  31  1................................SVSAGEKPPRLYDRRSIFDAVAQSNCQELESLL-PFLQRSKKRPETGKTCLLKAMLNGQNDTIALLLDVARKTDSASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSADISARDSVGNTVLHALVEVADNTVDNSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEP............................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 260
23 -63.8002etc_A mol:protein length:274 Transient receptor potential cation channel subfamily V member 2  ali model follow..  31  3................................TSAPSQQEPDRFDRDRLFSVVSRGVPEELTGLLEYLRDSAYTEGSTGKTCLMKAVLNLQDACIMPLLQIDKDLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPASLEATDSLGNTVLHALVMIADSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREF--SGPYQPLAAA...................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 268
24 -63.6002f37_A mol:protein length:251 Transient receptor potential cation channel subfamily V member 2  ali model follow..  27  9.DRLFNAVSRGVPEDLAGLPEYLSKT---------------SKYLTDSEYTEGSTGKTCLMKAVL-------NLKDGVNACILPLLQIDRDSGNPQPLVN-------AQCTDDYYRGHSALHIAIEKRSLQCVKLLVENGANVHARACGRFFQKGQGTCFYFGELPLSLAACTKQWDVVSYLLENPASLQATDSQGNTVLHALVMISDNSAENSMYDGLLQAGARLCPTVQLEDIRNLQDLTPLKLAAKEGKIEIFRHILQREFS................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 251
25 -62.3004b93_B mol:protein length:269 ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 27  ali model follow..  20  12VEKLLRAVADGDLEMVRYLLEWTEEDLE----DAEDTVSAADPEFCHPLCQCPKCAPAQKRLAKVPASGLGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANAGAR-----NADQAVPLHLACQQGHFQVVKCLLDSNAKPNKKDLS-------------GNTPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEAVIEKHVFVV----ELLLLHGASVQ-------VLNKRQRTAVDCAEQNSKIQVVPSCVASLDDVAETDRKEYVTVKIRK................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 263
26 -61.1003jxi_A mol:protein length:260 Vanilloid receptor-related osmotically activated channel protein  ali model follow..  32  2.........................................KVFNRPILFDIVSRGSPD-LLSFLLTHKKRLTREPSTGKTCLPKALLNGRNDTIPILLDIAEKTGNSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGADLRRQDSRGNTVLHALVAIADNTRENKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREI.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 249
27 -60.8004n5q_A mol:protein length:257 Transient receptor potential cation channel subfamily V member 3  ali model follow..  26  5.KRIFAAVSEGCVEELRELLQDLQDLCRRRR-------GLDVPDFLMHKLTASDTGKTCLMKALL-------NINPNTKEIVRILLAFAEENDILDRFIN-------AEYTEEAYEGQTALNIAIERRQGDITAVLIAAGADVNAHAKGVFFNPKQHEGFYFGETPLALAACTNQPEIVQLLMENETDITSQDSRGNNILHALVTVAENDFVKRMYDMILLRSGNWE----LETMRNNDGLTPLQLAAKMGKAEILKYILSREIK................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 250
28 -60.2002eta_A mol:protein length:256 Transient receptor potential cation channel subfamily V member 2  ali model follow..  27  4.DRLFSVVSRGVPEELTGLLEYLRWN---------------SKYLTDSAYTEGSTGKTCLMKAVL-------NLQDGVNACIMPLLQIDKDSGNPKPLVN-------AQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPASLEATDSLGNTVLHALVMIADNSLVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGAAA............................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 250
29 -59.9006g1k_A mol:protein length:921 Transient receptor potential cation channel subfamily c member 4a  ali model follow..  13  1..GSQLYFRRTDNSSYRDRIPL-----------RIVRAESELSTQEKSYLSAVEKGDYASVKLALEEFKININCIDPLGRTALLIAIENENLEIIELLLSFNVYVG------------DALLHAIRKEVVGAVELLLNHKKPSGEKQVPPILLDKQFSDFTPDITPIILAAHTNNYEIIKMLVQKGVSVPQPHEVRCNCVECVSSSDVDSLRHSRSRLNIYKALASPSLIAL------SSEDPFLTAFQLSWE--LQELSKVENEFKAEYEELSHQCKHLDQTRSSRELELILNFRDDMNLLQDEANNELARLKLAIKYRQKEFVAIKFICHTASYLTFLFLLLLASQHIVSNNPD-----------------------RQGPKPTTVEWMILPWVLGFIWTEIKQMWDGGFQDYIHDW-----WNLMDFVMNSLYLATISLKIVAYVKYEAVFAIANIFSSLRLISLFTANSHLGPLQISLGRML-LDILKFLFIYCLVLLAFANGLNQLYFYYENSENNAFSTLFETLQSLFWSIFGLISLYVTNVKATEFVGATMFGTYNVISLVVLLNMLIAMMNNSYQHIADHADIEWKFARTKLWMSYFEELPPWIKVHVFKRRSKRTETFGTLGRRAAENVRLNHQYQEVLRNLVKRYVAAMIRDAKTEEGLTEENFKELKQDISSFRYEVIGMMKGNRKSTR.............................. 761
30 -59.2006ar6_B mol:protein length:328 DLD-4 darpin  ali model follow..  18  5.KKLLEAARAGQDDEVRILMANGADVNADDLLKNGADVNADDVHGRTPLHLAAGRGHLEIVEVL---HGADVNAPDRWGRTPLHLAAHHGHLEIVEVLLKYGADVNAQ-----DKFGKTAFDISIDSGNEDLAEILQSSSEFGGGGSGGG--GSGGGGSASDLGKKLLEAARAGQDDEVRILMANGADVNATDHLGVTPLHLAAVLGHLEIV----EVLLKHGADVN-------AYDILGRTPLHLAAWRGHLEIVEVLLKYGADVNADDTSGTTPLHLAAG---EGHLEIVEVLLKYGADVNAQDKFGKTAFDISIDNGNEDLAEIL.................................................................................................................................................................................................................................................................................................................................................................................................................. 328
31 -59.1003ljn_A mol:protein length:364 hypothetical protein  ali model follow..  15  21MEKIHVAARKGQTDEVRRLIETG------------VSPTIQNRFGCTALHLACKFGCVDTAKYLA-SVGEVHSLWH--GQKPIHLAVMANKTDLVVALVEGAKEVNEIGSHVKHCKGQTALHWCVGLGYLEMIKILVQLGASPTAKDKA-------------DETPLMRAMEFRNREALDLMMDSSLRLDYANKQGNSHLHWAILINWEDVA----MRFVEMGIDVN-------MEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQACPYHNGT-FVPAAADPSKQEVLQLLQEKLDEVVRSLNTGAGGAVKRKKKAAPAVKRMKLAPSAPVRTRSRSRARSSAVSK............................................................................................................................................................................................................................................................................................................................................................................................ 364
32 -59.0001ot8_A mol:protein length:239 Neurogenic locus Notch protein  ali model follow..  19  4.TPLMIAAVRGGGLDTGEDIENNEDSTAQVLLAQGAELNATDKTGETSLHLAARFARADAAKRLL-DAGADANSQDNTGRTPLHAAVAADAMGVFQILLRNRA----TNLNARMHDGTTPLILAARLAIEGMVEDLITADADINAADNS-------------GKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEAS----KALLDNFANRE-------ITDHMDRLPRDVASERLHHDIVRLLDEH.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 239
33 -58.9001oy3_D mol:protein length:282 transcription factor inhibitor I-kappa-B-beta  ali model follow..  19  11.TALHLAVIHQHEPFLDFLLGFSAGHEY---------LDLQNDLGQTALHLAAILGEASTVEKLY-AAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDASEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTC------------GRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILA----RLLRAHGAPEP-------EDGGDKLSPCSSSGSDSDSDNRDEGDEYD................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 281
34 -58.8001k3z_D mol:protein length:282 transcription factor inhibitor I-kappa-B-beta  ali model follow..  19  11.TALHLAVIHQHEPFLDFLLGFSAGHEY---------LDLQNDLGQTALHLAAILGEASTVEKLY-AAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDASEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTC------------GRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILA----RLLRAHGAPEP-------EDGGDKLSPCEEEGEDEDSDNRDEGDEYD................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 281
35 -58.2001n11_A mol:protein length:437 Ankyrin  ali model follow..  17  15LTPLHVASFMGHLPIVKNLLQRGASPNVSNVLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLL-ENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACM-----TKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKN-------------GLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVA----RSLLQYGGSAN-------AESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQ---EGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLK.................................................................................................................................................................................................................................................................................................................................................. 397
36 -57.5002f8x_K mol:protein length:256 Neurogenic locus notch homolog protein 1  ali model follow..  19  25LETGNSEEEEDAPAVISDFIYQGASLH-----------NQTDRTGETALHLAARYSRSDAAKRLL-EASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRA----TDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDL-------------GKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETA----KVLLDHFANRD-------ITDHMDRLPRDIAQERMHHDIVRLLDEYNLVRSPQLH........................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 255
37 -57.5001ycs_B mol:protein length:239 53BP2  ali model follow..  15  7.VSLPPGKRTNLRKTGSERIAHGMRVK-------------FNPLPLALLLDSSLEGEFDLVQRII-YEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAA-----DSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSD----------MQTAADKCEEMEEGYTQCSQFLYGVQEKMGIMNKGVIYALWDYEPQNDDEL-------PMKEGDCMTIIHWWARLNDKEGYVPRNLLGLYPRIKPRQRSLA..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 239
38 -57.4005et0_A mol:protein length:354 Espin  ali model follow..  18  40.LPVHHAARSGKLHCLRYLVEEVA-----------LPAVSRARNGATPAHDAAATGYLSCLQWLLTQGGCRVQEKDNSGATVLHLAARFGHPDVVKWLLYQGG----ANSAITTDTGALPIHYAAAKGDLPSLKLLVGHYPE------------GVNAQTNNGATPLYLACQEGHLEVTKYLVQESADPHLRAQDGMTPLHAAAQMGHNPVLVWLVS----------FADVSFSEQDHDGATAMHFAASRGHTKVLSWLLLHGAEIS-QDLWGGTPLHDAAE---NGELECCQILAVNGAGLDVRDHDGYTAADLAEFNGHTHCSRYLRVQTLSLEHRVLSRDQSMDL.............................................................................................................................................................................................................................................................................................................................................................................................. 347
39 -57.3006by9_A mol:protein length:328 Histone-lysine N-methyltransferase EHMT1  ali model follow..  14  3.AAGPPLSEDDKLQGAASHVPEG------------FDPTGPAGLGRPTPGLSQGPGKETLESALI-ALDSEKPKKLRFHPKQLYFSARQGELQKVLLMLVDGIDPNFK---MEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSED-------------QRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLS----------NGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAF---SGCVDIAEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFL------------------------------SRDSDVTLKNKEGETPLQCASLNSQVWSALQMSKALQDS............................................................................................................................................................................................................................................................................................................................................ 327
40 -57.2001ikn_D mol:protein length:236 PROTEIN (I-KAPPA-B-ALPHA)  ali model follow..  21  10.SFLHLAIIHEEKALTMEVIRQ--------VKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALL-GAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSIKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEP------------CNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE-----------NLQMLPESEDEESYDTESEFTEFTE......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 234
41 -56.9004o60_A mol:protein length:234 ANK-N5C-317  ali model follow..  31  7.KKLLEAARAGHDDSVEVLLKKG------------ADINAKDNVGVTPLHLAAVNGHLELVKLLL-EKGADINATDLFGLTPLHFAATNGHLELVKLLLEKGADINAV-----DDVGVTPLHFAARNGHLELVKLLLEKGADINAMDMV-------------GPTPLHFAAKNGHLELVKLLLEKDADINAEDHFGSTPLHSAAENGHLELV----KLLLEKGADIN-------ARDKFGKTPFDLAIDNGNEDIAEVLQKAARS................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 228
42 -56.8004qfv_A mol:protein length:234 ANK-N5C-281  ali model follow..  32  7.KKLLEAARAGHDDSVEVLLKKG------------ADINAKDNSGRTPLHVAALNGHLELVKLLL-EKGADINARDMFGLTPLHTAASNGHLELVKLLLEKGADINAR-----DEDGSTPLHLAASNGHLELVKLLLEKGADINAEDHS-------------GTTPLHFAAKNGHLELVKLLLEKGADINASDFSGPTPLHSAAENGHLELV----KLLLEKGADIN-------ARDKFGKTPFDLAIDNGNEDIAEVLQKAARS................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 228
43 -56.7004nik_A mol:protein length:230 26S proteasome non-ATPase regulatory subunit 10  ali model follow..  21  13.MVCNLAYSGKLEELKESILA------------DKSLATRTDQDSRTALHWACSAGHTEIVEFLL-QLGVPVNDKDDAGWSPLHIAASAGRDEIVKALLGKGAQVNAV-----NQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHY-------------EATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEA----KLLVSQGASIY-------IENKEEKTPLQVAKG-GLGLILKRMVEG.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 230
44 -56.7002qc9_A mol:protein length:210 Notch 1 protein  ali model follow..  21  2.............SVISDFIYQGASLH-----------NQTDRTGETALHLAARYSRSDAAKRLL-EASADANIQDNMGRTPLHAAVSADAQGVFQILLRNRA----TDLDARMHDGTTPLILAARLALEGMLEDLINSHADVNAVDDL-------------GKSALHWAAAVNNVDAAVVLLKNGANKDMQNNKEETPLFLAAREGSYETA----KVLLDHFANRD-------ITDHMDRLPRDIAQERMHHDIVRLLDEY.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 210
45 -56.6004cym_D mol:protein length:203 ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 27  ali model follow..  18  2..............PLGSMDPSV------------VTPFSRDDRGHTPLHVAAVCGQASLIDLLV-SKGAMVNATDYHGATPLHLACQKGYQSVTLLLLHYKASAEVQ-----DNNGNTPLHLACTYGHEDCVKALVYYDVE----------SCRLDIGNEKGDTPLHIAARWGYQGVIETLLQNGASTEIQNRLKETPLKCALNSKI-------LSVMEAYHLSFE-------RRQKSSEAPVQSPQRSVD.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 197
46 -56.2002dvw_A mol:protein length:231 26S proteasome non-ATPase regulatory subunit 10  ali model follow..  20  8.IMICNLAYSGKLDELKERI-----------LADKSLATRTDQDSRTALHWACSAGHTEIVEFLL-QLGVPVNDKDDAGWSPLHIAASAGRDEIVKALLVKGAHVNAV-----NQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHY-------------DATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEA----KFLVTQGASIY-------IENKEEKTPLQVAK--GGLGLILKRLAEGEEAS............................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 230
47 -56.2005le6_A mol:protein length:324 DD_D12_09_D12  ali model follow..  22  10.KKLLEAARAGQDDEVRILLANG------------ADVNTADETGFTPLHLAAWEGHLGIVEVLL-KNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNAT-----DVIGTAPLHLAAMWGHLEIVEVLLKNGADVSAQDKFGKTPRDWKLLLDALKYLLLEAAREGHRDRVEKLIKAGADVNTADETGFTPLHLAAWEGHLGIV----EVLLKNGADVN-------ANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAM---WGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA.............................................................................................................................................................................................................................................................................................................................................................................................................. 318
48 -56.0006emk_G mol:protein length:426 Target of rapamycin complex 2 subunit AVO2  ali model follow..  10  7.VRLREAIIEGNLLIVKRLLRRNPDLLT----------NIDSENGWSSLHYASYHGRYLICVYLI-QLGHDKHEKTFKGNTCVHLALMKGHEQTLHLLLQQFPRF----INHRGENGRAPIHIACMNDYYQCLSLLIGVGADLWVMDTN-------------GDTPLHVCLEYGSISCMKMLLNEGEDDNVRDKGNWKPIDVAQTFEVGNIYSKVLKEVKKKGPPLGAGK-----KPSSFRTPILNAKATFE-DGPSPVLSMNSPYSLYSNNSPLPVLPRRI---STHTTSGNGGNRRSSITNPVFNPRKPTLSTDSFSSSSNSSSRLRVNSINVKTPVHSATPTSPHNNIALINRYLLPNKSNDNVRGDSQTATINDDGGGGNGGDATIGMGLRK.............................................................................................................................................................................................................................................................................................................................................. 383
49 -56.0004rly_A mol:protein length:329 Nav1.2 - AnkB chimera  ali model follow..  18  2.STVTVPIAVGESDFENLNTEGS------------LVPRGSKSDSNASFLRAARAGNLDKVVEYL-KGGIDINTCNQNGLNALHLAAKEGHVGLVQELLGRGSSVDSA-----TKKGNTALHIASLAGQAEVVKVLVKEGANINAQSQN-------------GFTPLYMAAQENHIDVVKYLLENGANQSTATEDGFTPLAVALQQGHNQAVAILLELLLQNDHNADVQSKMMNRTTESGFTPLHIAAHYGNVNVATLLLNRGAAVDFTARNGITPLHVASK---RGNTNMVKLLLDRGGQIDAKTRDGLTPLHCAARSGHDQVVELLKVVTEEVTT......................................................................................................................................................................................................................................................................................................................................................................................................... 329
50 -56.0001k1a_A mol:protein length:241 B-cell lymphoma 3-encoded protein  ali model follow..  21  11.TPLHIAVVQGNLPAVHRLVN--------LFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLV-TAGASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAP-GTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDI------------KSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLV----RTLVRSGADSS-------LKNCHNDTPLMVARSRRVIDILRGKATRPAS................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 241
51 -56.0001yyh_A mol:protein length:253 Notch 1, ankyrin domain  ali model follow..  20  24LETGNSEEEEDAPAVISDFIYQGASLH-----------NQTDRTGETALHLAARYSRSDAAKRLL-EASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRA----TDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDL-------------GKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETA----KVLLDHFANRD-------ITDHMDRLPRDIAQERMHHDIVRLLDLE.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 245
52 -55.8004rlv_A mol:protein length:910 Ankyrin-1, Ankyrin-2  ali model follow..  18  230LPALHIAARKDDTKSAALLLQNDHNAD----VQSKMMVNRTTESGFTPLHIAAHYGNVNVATLLL-NRGAAVDFTARNGITPLHVASKRGNTNMVKLLLDRGGQIDAK-----TRDGLTPLHCAARSGHDQVVELLLERGAPLLARTKNGLSKAPVDDVTLDYLTALHVAAHCGHYRVTKLLLDKRANPNARALNGFTPLHIACKKNRIKVM----ELLVKYGASIQ-------AITESGLTPIHVAAFMGHLNIVLLLLQNGASPDVTNIRGETALHMAAR---AGQVEVVRCLLRNGALVDARAREEQTPLHIASRLGKTEIVQLLLQHMAHPDAATTNGYTPLHISGQVDVASVLLEAGAAHSLATKKGFTPLHVAAKYGSLDVAKLLLQRRAAADS.......................................................................................................................................................................................................................................................................................................................................... 628
53 -55.8005y4e_A mol:protein length:277 Ankyrin-2,Ankyrin-2  ali model follow..  21  17.DSLPSSQFLDGMNYLRYSLEGGRSLVPR---------GSGSRNGITPLHVASKRGNTNMVKLLL-DRGGQIDAKTRDGLTPLHCAARSGHDQVVELLLERGAPLLAR-----TKNGLSPLHMAAQGDHVECVKHLLQHKAPVDDVTLD-------------YLTALHVAAHCGHYRVTKLLLDKRANPNARALNGFTPLHIACKKNRIKVM----ELLVKYGASIQ-------AITESGLTPIHVAAFMGHLNIVLLLLQNGASPDVTNIRGETALHMAAR---AGQVEVVRCLKVVTEEVTT.......................................................................................................................................................................................................................................................................................................................................................................................................................................... 277
54 -55.7005le9_A mol:protein length:324 DD_Off7_09_3G124  ali model follow..  21  10.KKLLEAARAGQDDEVRILMANG------------ADVNAADNTGTTPLHLAAYSGHLEIVEVLL-KHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADVNAM-----DSDGMTPLHLAAKWGYLEIVEVLLKHGADVSAQDKFGKTPRDWKLLLDALKYLLLEAAREGHRDRVEKLIKAGADVNAADDVGVTPLHLAAQRGHLEIV----EVLLKCGADVN-------AADLWGQTPLHLAATAGHLEIVEVLLKNGADVNARDNIGHTPLHLAAW---AGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA.............................................................................................................................................................................................................................................................................................................................................................................................................. 318
55 -55.4003utm_A mol:protein length:351 Tankyrase-1  ali model follow..  17  2..........EFGKSALDLADPS------------AKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAK-----DKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLW-------------QFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFKGHSLLQAAREALEIINFKQPQSHETALHCAVASLHKQVAELLLRKGANVNEKNKDFMTPLHVAAE---RAHNDVMEVLHKHGAKMNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQM.............................................................................................................................................................................................................................................................................................................................................................................................. 319
56 -55.2005jhq_A mol:protein length:482 Tankyrase-1  ali model follow..  14  16LRELLEACRNGDVSRVKRLVD-----------AANVNAKDMAGRKSSPLHFAAGFGRKDVVEHLL-QMGANVHARDDGGLIPLHNACSFGHAEVVSLLLCQGADPNAR-----DNWNYTPLHEAAIKGKIDVCIVLLQHGADPNIRNTDGKSNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVT----ELLLKHGACVN-------AMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPQVTELLLRKGANVNEKNKDFMTPLHVRAHNDVMEVLHKHGAKMNALDTLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGNEAVQQILSES................................................................................................................................................................................................................................................................................................................... 475
57 -55.2005leb_A mol:protein length:473 DDD_D12_06_D12_06_D12  ali model follow..  17  9GKKLLEAARAGQDDEVRILLANG------------ADVNTADETGFTPLHLAAWEGHLGIVEVLL-KNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNAT-----DVIGTAPLHLAAMWGHLEIVEVLLKNGADVFAQDKFGKTGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIV----EVLLKNGAGVN-------ATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVFAQDKFGKTPFDLARDAARQGQRDRVEKLMANGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVNA.......................................................................................................................................................................................................................................................................................................................................... 439
58 -55.1004uuc_A mol:protein length:226 ANKYRIN REPEAT AND SOCS BOX PROTEIN 11  ali model follow..  21  6.SPLHEAAAQGRLLALKTLIAQG------------VNVNLVTINRVSSLHEACLGGHVACAKALL-ENGAHVNGVTVHGATPLFNACCSGSAACVNVLLEFGAKAQLEV------HLASPIHEAVKRGHRECMEILLANNVNIDHEVPQ-------------LGTPLYVACTYQRVDCVKKLLELGASVD-HGQWLDTPLHAAARQSNVEVI----HLLTDYGANLK-------RRNAQGKSALDLAAPKSSVEQALLLREGPPAL................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ 226
59 -55.0005le3_A mol:protein length:317 DD_D12_09_D12  ali model follow..  22  10.KKLLEAARAGQDDEVRILLANG------------ADVNTADETGFTPLHLAAWEGHLGIVEVLL-KNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNAT-----DVIGTAPLHLAAMWGHLEIVEVLLKNGADVSAQDKFGKTPAGDNGNEWIAKKLLLAAAREGHREAVERAIKAGADVNTADETGFTPLHLAAWEGHLGIV----EVLLKNGADVN-------ANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAM---WGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA.............................................................................................................................................................................................................................................................................................................................................................................................................. 311
60 -55.0005lem_A mol:protein length:326 DD_Off7_11_3G124  ali model follow..  20  10.KKLLEAARAGQDDEVRILMANG------------ADVNAADNTGTTPLHLAAYSGHLEIVEVLL-KHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADVNAM-----DSDGMTPLHLAAKWGYLEIVEVLLKHGALVKAKDKFGKTPKDLARDNELLEKLLLEAAREGHRDRVEEFIKRGADVNAADDVGVTPLHLAAQRGHLEIV----EVLLKCGADVN-------AADLWGQTPLHLAATAGHLEIVEVLLKNGADVNARDNIGHTPLHLAAW---AGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA.............................................................................................................................................................................................................................................................................................................................................................................................................. 320
61 -54.9005le7_A mol:protein length:328 DD_D12_13_D12  ali model follow..  21  10.KKLLEAARAGQDDEVRILLANG------------ADVNTADETGFTPLHLAAWEGHLGIVEVLL-KNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNAT-----DVIGTAPLHLAAMWGHLEIVEVLLKNGADVNAQDKFGKTPEDEEAKKEDLDRKLLEAARAGHRDEVEDLIKNGADVNTADETGFTPLHLAAWEGHLGIV----EVLLKNGADVN-------ANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAM---WGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA.............................................................................................................................................................................................................................................................................................................................................................................................................. 322
62 -54.8005aq9_A mol:protein length:422 OFF7_DB08V4  ali model follow..  14  10.RKLLEAARAGQDDEVRILMANG------------ADVNAADNTGTTPLHLAAYSGHLEIVEVLL-KHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADVNAM-----DSDGMTPLHLAAKWGYLEIVEVLLKHGADVNAQDKF-------------GKTPFDLADDNGNDDVGTLLQVAAAADQLGARVGYIELDLNSGKILESFRSEMSTFKVLLAGAIL-------SRIDAGQEQLGRRIHYSQNDLVMTVRELASAAITMSDNTAANLLLTTI----GPKGLTAFLHNMGDHVTRLD--WEPELNEAIPNDERDTTTPVAMATTLRKLLTGELLTPASRQQLMDWMEADKVAGPLLRSVLPAGWFIADKSGAGERGSRGIVAAL................................................................................................................................................................................................................................................................................................................................................. 377
63 -54.6005le4_A mol:protein length:326 DD_D12_11_D12  ali model follow..  21  10.KKLLEAARAGQDDEVRILLANG------------ADVNTADETGFTPLHLAAWEGHLGIVEVLL-KNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNAT-----DVIGTAPLHLAAMWGHLEIVEVLLKNGALVKAKDKFGKTPKDLARDNELLEKLLLEAAREGHRDRVEEFIKRGADVNTADETGFTPLHLAAWEGHLGIV----EVLLKNGADVN-------ANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAM---WGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA.............................................................................................................................................................................................................................................................................................................................................................................................................. 320
64 -54.5005lw1_A mol:protein length:326 DD_232_11_D12  ali model follow..  21  10.KKLLEAARAGQDDEVRILMANG------------ADVNASDQLGITPLHLVAITGHLEIVEVLL-KNGADVNAHDFVGTTPLHLAAFLGHLEIVEVLLKYGADVNAV-----DRDGLTPLHLAAIHGHLEIVEVLLKHGALVKAKDKFGKTPKDLARDNELLEKLLLEAAREGHRDRVEEFIKRGADVNTADETGFTPLHLAAWEGHLGIV----EVLLKNGADVN-------ANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAM---WGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA.............................................................................................................................................................................................................................................................................................................................................................................................................. 320
65 -54.5003ui2_A mol:protein length:244 Signal recognition particle 43 kDa protein, chloroplastic  ali model follow..  17  17.MEYLIEWKDGHSPSWVPSSYIAADVVSE---------------YETPWWTAARKADEQALSQLL--EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD----MRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERGLTAAREILKTTPKGNPMQFGRRIGLEKVINVLEGQVFEYAEVDEKGKDVEYLVRWKDGGDCEWVKGVHVAE-------------DVAKDYEDGLEYAVAESVI............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 243
66 -54.5005aqa_A mol:protein length:418 OFF7_DB04V3  ali model follow..  14  10.RKLLEAARAGQDDEVRILMANG------------ADVNAADNTGTTPLHLAAYSGHLEIVEVLL-KHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADVNAM-----DSDGMTPLHLAAKWGYKEIVEVLLKAGADVDAQDKF-------------GKRPLWLAADQGHAEIAAKLVAARLKARVGYIELDLNSGKILESVRSE--PMMSTFKVLLAGAILS-------RIDAGQEQLGRRIHYSQNDLVEYVRELASAAITMSDNTAANLLLTTI----GPKGLTAFLHNMGDHVTRLD--WEPELNEAIPNDERDTTTPVAMATTLRKLLTGELLTPASRQQLMDWMEADKVAGPLLRSVERGSRGIVAALGPDGKPSRIVVIYTTGS.............................................................................................................................................................................................................................................................................................................................................. 390
67 -54.4005ma5_A mol:protein length:302 K11  ali model follow..  21  8.KKLLEAARAGQDDEVRILMANG------------ADVNAADDVGVTPLHLAAQRGHLEIVEVLL-KYGADVNAADLWGQTPLHLAATAGHLEIVEVLLKNGADVNAR-----DNIGHTPLHLAAWAGHLEIVEVLLKYGADVNAQDKF-------------GKTPFDLAIDNGNEDIAEVLQKGGGDVNAYDEVGWTPLHKAAWGH-----LEKVEDLLKNGADVN-------AADIDGYTPLHLAAFSGHLEIVEVLLKYGADVNADDQAGFTPLHLAAI---FGHLEIVEVLLKNGADVNAQDKFGKTPFDLAIDNGNEDIAEILQKAA.............................................................................................................................................................................................................................................................................................................................................................................................................. 302
68 -54.4003eu9_A mol:protein length:240 Huntingtin-interacting protein 14  ali model follow..  19  1....................................HMTHIDDYSTWDIVKATQYGIYERCRELV-EAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLG----GDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGE-------------GCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHS---VDPTRLLLTFNVSVNLGD------KYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLAKQ---RKNVWMINHLQEARQAKGYDN........................................................................................................................................................................................................................................................................................................................................................................................................................................ 240
69 -54.2005cea_A mol:protein length:230 Bd3460  ali model follow..  22  1.....MKKSYLLAALIFAGLLHGTAFA-------------MSGKSSKALNEAAEQGDLAKVKNLVQKNKIDLNAQDETGMTPLMNAAMGGNLDIVKFLLSKKVNLELK-----NNGGETALAFAVTNDAYDVAEELIKAGANVDIIVAG-----------DEGDTLFMRAAQNNKKTAESILAKNKSLINKANTLGETALFAVARYGTPADI----DFLIKKGADLK-------LKNKKGQTALDVAKEASNQDTAKALSKKKLE................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 222
70 -54.2005w7i_A mol:protein length:239 Palmitoyltransferase ZDHHC17  ali model follow..  24  14.WDIVKATQYGIYERCRELVEAG------------YDVRQPDKENVTLLHWAAINNRIDLVKYYI-SKGAIVDQLGGDNSTPLHWATRQGHLSMVVQLMKYGADPSLI-----DGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQN-------------GMTPLMWAAYRTHVDPTRLLLTFNVSVNLGDKHKNTALHWAVLAGNTTVI----SLLLEAGANVD-------AQNIKGESALDLAKQRKNVWMINHLQEARQA................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 238
71 -54.1005aar_A mol:protein length:185 POTASSIUM CHANNEL AKT1  ali model follow..  21  3.LNLCFAAIREDDLLLHQLLKRG------------LDPNESDNNGRTPLHIAASKGTLNCVLLLL-EYHADPNCRDAEGSVPLWEAMVEGHEKVVKVLLEHGSTIDAG-----DVGHFACT--AAEQGNLKLLKEIVLHGGDVTRPRAT-------------GTSALHTAVCEENIEMVKYLLEQGADVNKQDMHGWTPRDLAEQQGHEDIKALFRE................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 185
72 -53.9001wg0_A mol:protein length:243 Probable 26S proteasome regulatory subunit p28  ali model follow..  20  1...........................................MSNYPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLDDY--PDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDL-----------NKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCG----------LGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKGAEYDLVDNKGAKAEDVAL------NEQVKKFFLNNVVDKLAAA........................................................................................................................................................................................................................................................................................................................................................................................................................................ 235
73 -53.9005le8_A mol:protein length:330 DD_D12_15_D12  ali model follow..  21  10.KKLLEAARAGQDDEVRILLANG------------ADVNTADETGFTPLHLAAWEGHLGIVEVLL-KNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNAT-----DVIGTAPLHLAAMWGHLEIVEVLLKNGADVRAQDKFGKTPEKAERKLKDLDRKLLEAARAGHRDEVEDLIKNGADVNTADETGFTPLHLAAWEGHLGIV----EVLLKNGADVN-------ANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAM---WGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA.............................................................................................................................................................................................................................................................................................................................................................................................................. 324
74 -53.8006f5e_A mol:protein length:325 DD_D12_10_47  ali model follow..  21  10.KKLLEAARAGQDDEVRILLANG------------ADVNTADETGFTPLHLAAWEGHLGIVEVLL-KNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNAT-----DVIGTAPLHLAAMWGHLEIVEVLLKNGADVNAQDKFGKTPYDLATKRAALRRKLLEAARAGHRDEVEDLIKNGADVNAIDAMGLTPLHLAAMRGHLEIV----EVLLKYGADVN-------AEDYYGTTPLRLAAYIGHLEIVEVLLKYGADVNAYDISGTTPLHLAAV---LGHLEIVEVLLKYGADVNAQDKFGKTAFDISIDNGNEDLAEILQ................................................................................................................................................................................................................................................................................................................................................................................................................. 316
75 -53.8003d9h_A mol:protein length:285 cDNA FLJ77766, highly similar to Homo sapiens ankyrin repeat and SOCS box-containing 9 (ASB9), transcript variant 2, mRNA  ali model follow..  18  23.GGMDGSKPAGPRDFPGIRLLSNPLMG-------------DAVSDWSPMHEAAIHGHQLSLRNLI-SQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGV-----TADWHTPLFNACVSGSWDCVNLLLQHGASVQPESD--------------LASPIHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACV----KKLLESGADVN--------QGKGQDSPLHAVVRTASEELACLLMDFGADTQAKNAEGKRPVELVPP----ESPLAQLFLEREGASLPKPK........................................................................................................................................................................................................................................................................................................................................................................................................................................ 278

FFAS is supported by the NIH grant R01-GM087218-01
1 3 7 8 0 7   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Sasin JM, Godzik A, Bujnicki JM. SURF'S UP! - protein classification by surface comparisons. J Biosci. 2007 Jan;32(1):97-100.